tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

OCGN Stock Latest News

Ocugen announces IND in effect after FDA review
The FlyOcugen announces IND in effect after FDA review
3d ago
OCGN
Ocugen announces first patient dosed in Phase 1 OCU200 trial for DME
PremiumThe Fly
Ocugen announces first patient dosed in Phase 1 OCU200 trial for DME
14d ago
OCGN
Ocugen reports ‘positive’ update from Phase 1/2 OCU400 trial
PremiumThe Fly
Ocugen reports ‘positive’ update from Phase 1/2 OCU400 trial
17d ago
OCGN
Ocugen’s Phase 1/2 study of OCU410 approved for continuation by DSMB
PremiumThe Fly
Ocugen’s Phase 1/2 study of OCU410 approved for continuation by DSMB
1M ago
OCGN
Ocugen announces EMA granted orphan medicinal product designation for OCU410ST
PremiumThe Fly
Ocugen announces EMA granted orphan medicinal product designation for OCU410ST
2M ago
OCGN
Ocugen announces preliminary efficacy, safety data from Phase 1/2 OCU410 trial
PremiumThe FlyOcugen announces preliminary efficacy, safety data from Phase 1/2 OCU410 trial
2M ago
OCGN
OCGN Stock: Can New Leadership Save This Biotech Company?
Premium
Market News
OCGN Stock: Can New Leadership Save This Biotech Company?
2M ago
OCGN
Ocugen Appoints Ramesh Ramachandran as Financial Officer
Premium
Company Announcements
Ocugen Appoints Ramesh Ramachandran as Financial Officer
3M ago
8K
OCGN
Ocugen to Present Innovations at Nasdaq Clinical Showcase
PremiumCompany Announcements
Ocugen to Present Innovations at Nasdaq Clinical Showcase
3M ago
8K
OCGN
Ocugen: Progress in Gene Therapy and Financial Outlook
PremiumCompany Announcements
Ocugen: Progress in Gene Therapy and Financial Outlook
3M ago
OCGN
OCGN Earnings: Ocugen’s Q3 Results Disappoint
PremiumMarket News
OCGN Earnings: Ocugen’s Q3 Results Disappoint
3M ago
OCGN
Options Volatility and Implied Earnings Moves Today, November 08, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, November 08, 2024
3M ago
TU
BAX
Ocugen reports Q3 revenue $1.136M, consensus $300,000
PremiumThe FlyOcugen reports Q3 revenue $1.136M, consensus $300,000
3M ago
OCGN
OCGN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
OCGN Earnings this Week: How Will it Perform?
3M ago
OCGN
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
API
VFS
Ocugen announces DSMB for OCU410ST trial approved enrollment for second phase
PremiumThe Fly
Ocugen announces DSMB for OCU410ST trial approved enrollment for second phase
3M ago
OCGN
Etsy, Enphase downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Etsy, Enphase downgraded: Wall Street’s top analyst calls
4M ago
BX
CEG
Maxim starts Ocugen at Buy on large addressable market sizes
PremiumThe Fly
Maxim starts Ocugen at Buy on large addressable market sizes
4M ago
OCGN
Ocugen initiated with a Buy at Maxim
PremiumThe Fly
Ocugen initiated with a Buy at Maxim
4M ago
OCGN
Ocugen Advances Promising Pipeline Amid Financial Restraints
PremiumMarket NewsOcugen Advances Promising Pipeline Amid Financial Restraints
4M ago
OCGN
Ocugen: FDA lifts clinical hold on IND application for OCU200 Phase 1 trial
Premium
The Fly
Ocugen: FDA lifts clinical hold on IND application for OCU200 Phase 1 trial
4M ago
OCGN
Ocugen’s (OCGN) Stock Has Surged 195% on Promising Gene Therapy Treatment
Premium
Market News
Ocugen’s (OCGN) Stock Has Surged 195% on Promising Gene Therapy Treatment
5M ago
OCGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >